Latest Breaking News On - Treadwell announces ocifisertib - Page 1 : comparemela.com

Currently, ocifisertib is being evaluated in a phase 1b and 2 trial to confirm the safety and tolerability profiles in patients with acute myeloid leukemia.

Roger sidhuTreadwell therapeuticsTreadwell announces ocifisertibReceived orphan designationAcute myeloidPatients with advanced